Cancer patients who seek care at Lifespan will continue to receive treatment at its Rhode Island facilities, but those with “more rare and complex cancers will benefit from seamless referrals and coordination of care with Dana-Farber,” Timothy Babineau, president and CEO of Lifespan, told the Providence Journal.
The partners will also create a program to coordinate treatment for Lifespan patients undergoing bone marrow transplants at Dana-Farber in Boston so they can receive pre- and post-operative treatment at Lifespan’s Rhode Island Hospital in Providence.
More articles on clinical partnerships:
Christiana Care Health System partners with Thomas Jefferson University on gene counseling master’s program
22 recent hospital transactions and partnerships
IBM Watson, MedyMatch Technology partner to identify head trauma, stroke bleeding
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
